Matilda Nicholas is a Dermatology physician affiliated with Duke University. OpenAlex indexes 48 publications with 526 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
40 Duke Medicine Cir
Durham, NC 277104000
Telephone
919-684-8111Registry record last updated 25 Jun 2013.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Blueprint Medicines CorporationProgram year20253 payments
- SANOFI US SERVICES INC.Program year20251 payment
- Blueprint Medicines CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
26%Corticosteroid10.6%Triamcinolone Acetonide75%Fluocinolone Acetonide25%Part D≥50 patientsalpha-Hydroxy Acid6.6%Ammonium Lactate100%Part D≥33 patients+ 2 more classes in this area
Sensory organs
24.6%Corticosteroid23.2%Clobetasol Propionate70%Hydrocortisone18%Desonide12%Part D≥74 patientsOther antiinfectives1.5%Chlorhexidine Gluconate100%Part D<11 patientsAnti-infectives
17.3%Azole Antifungal10.1%Ketoconazole86%Fluconazole14%Part D<11 patientsLincosamide Antibacterial2.2%Clindamycin Phosphate100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2006–2008 per NIH RePORTER. The latest:
- Complement deficiency and environment in autoimmunity
Univ of North Carolina Chapel Hill
FY2008$28,048F30ES014519 - Complement deficiency and environment in autoimmunity
Univ of North Carolina Chapel Hill
FY2007$28,048F30ES014519 - Complement deficiency and environment in autoimmunity
Univ of North Carolina Chapel Hill
FY2006$28,048F30ES014519
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Disparities of itch severity in outpatient clinics as measured by the ItchyQuant
Journal of the American Academy of Dermatology
2026 - Mastocytosis: Part I: Pathogenesis, Clinical Presentation and Classification
Journal of the American Academy of Dermatology
2025 - Lymphoproliferative Disorders Mimicking Rheumatologic Disease: A Clinical Reasoning Perspective
Current Allergy and Asthma Reports
2025 - Mastocytosis: Part II: Diagnosis and Management of Mastocytosis through a Multidisciplinary Lens
Journal of the American Academy of Dermatology
2025 - Virtual care nurse triage protocols cost-effectively reduce dermatologist burnout
Dermatology Online Journal
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Califf, MD
Duke University
Pamela Douglas, MD
Duke University
Adrian Hernandez, MD
Duke University
John Perfect, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”